Tamer E. Fandy

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

María E. Figueroa, Lucy Skrabanek, Yushan Li et al. · Blood · 2009 · 331 citations · Full text

Medicine, Molecular Biology, Oncology +14

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies

Tamer E. Fandy, James G. Herman, Patrick Kerns et al. · Blood · 2009 · 288 citations · Full text

Medicine, Molecular Biology, Oncology +16

Interactive Effects of HDAC Inhibitors and TRAIL on Apoptosis Are Associated with Changes in Mitochondrial Functions and Expressions of Cell Cycle Regulatory Genes in Multiple Myeloma

Tamer E. Fandy, Sharmila Shankar, Douglas D. Ross et al. · Neoplasia · 2005 · 153 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Decitabine Induces Delayed Reactive Oxygen Species (ROS) Accumulation in Leukemia Cells and Induces the Expression of ROS Generating Enzymes

Tamer E. Fandy, Anchalee Jiemjit, Manjusha Thakar et al. · Clinical Cancer Research · 2014 · 88 citations · Full text

Medicine, Oncology, Pharmacology +11

p21WAF1/CIP1 induction by 5-azacytosine nucleosides requires DNA damage

Anchalee Jiemjit, Tamer E. Fandy, Hetty E. Carraway et al. · Oncogene · 2008 · 85 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +14